Justin Ezekowitz and C. Michael Gibson look at a sodium-reducing dietary intervention and its effects on patients with HF.

Episode 179: The SODIUM-HF Study

Shamir Mehta and C. Michael Gibson discuss how complete revascularization affects angina-related quality of life in patients with STEMI.

Episode 178: The COMPLETE Trial

Tijn Jansen, Suzette Elias-Smale, and C. Michael Gibson discuss whether diltiazem improves coronary vasomotor dysfunction in patients with angina and nonobstructive coronary artery disease.

Episode 177: The EDIT-CMD Trial

Mark Loeb and C. Michael Gibson discuss whether the influenza vaccine can reduce adverse vascular events among patients with HF.

Episode 176: The IVVE Trial

Gregory Lewis and C. Michael Gibson discuss how omecamtiv mecarbil affects exercise tolerance in patients with chronic HFrEF.

Episode 175: The METEORIC-HF Trial

Javed Butler and C. Michael Gibson discuss using patiromer to manage hyperkalemia in patients with HFrEF who are taking RAAS inhibitors.

Episode 174: The DIAMOND Trial

Florian Rader and C. Michael Gibson look at cumulative outcomes for patients with obstructive hypertrophic cardiomyopathy treated with mavacamten.

Episode 173: MAVA-LTE: The EXPLORER-LTE Cohort

Manesh Patel and C. Michael Gibson discuss the results of a phase II trial comparing the safety profiles of asundexian versus apixaban in patients with atrial fibrillation.

Episode 172:The PACIFIC-AF Study

Daniel Sessler and C. Michael Gibson compare myocardial injury rates following mild hypothermia versus aggressive warming during noncardiac surgery.

Episode 171: The PROTECT Trial

Duk-Woo Park and C. Michael Gibson discuss edoxaban vs dual antiplatelet therapy for valve thrombosis and cerebral thromboembolism after TAVI.

Episode 170: The ADAPT-TAVR Trial

A selection of the best interviews conducted by physician leaders and recorded at cardiology conferences around the globe.

Talking Points

C. Michael Gibson and Pieter Smits walk us through the COMPARE ABSORB trial.

Episode 73: COMPARE ABSORB

C. Michael Gibson speaks with Dominick Angiolillo about the 2018 North American Consensus Statement for Atrial Fibrilation Patients Undergoing PCI.

Episode 58: 2018 North American Consensus Statement for Atrial Fibrilation Patients Undergoing PCI

C. Michael Gibson and Myeong-Ki Hong discuss 5-year outcomes in this randomized trial.

Episode 96: IVUS-XPL: Intravascular Ultrasound-Guided vs. Angiography-Guided PCI

Usman Baber, who led this thrombogenicity substudy, walks C. Michael Gibson through the key findings.

Episode 97: TWILIGHT: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin

C. Michael Gibson speaks with Raj Makkar about PARTNER 3 Low-Risk Computed Tomography Substudy: Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves

Episode 80: PARTNER 3 Low-Risk Computed Tomography Substudy

C. Michael Gibson and Holger Thiele take a deep dive into a head-to-head trial of TAVR devices that also considered general versus local anesthesia.

Episode 69: SOLVE-TAVI: A 2x2 Randomized Trial of Transcather Aortic Valve Implantation

C. Michael Gibson speaks with Michael Mack about the COAPT Trial 3-year outcomes and results.

Episode 81: COAPT 3-Year Outcomes

C. Michael Gibson talks to William Gray about IMPERIAL: A Randomized Trial of Drug-Eluting Stents for Treatment of Femoropopliteal Artery Lesions.

Episode 59: IMPERIAL: A Randomized Trial of Drug-Eluting Stents

C. Michael Gibson speaks with Gregg Stone about EXCEL: 5-Year Outcomes From a Randomized Trial of PCI vs. CABG in Patients With Left Main Coronary Artery Disease.

Episode 82: EXCEL: 5-Year Outcomes

C. Michael Gibson discusses the AUGUSTUS trial with Renato Lopes.

Episode 83: The Medically Ill Patients in AUGUSTUS

C. Michael Gibson gets the details from DAPT-STEMI from Elvin Kedhi.

Episode 46: DAPT-STEMI

Early results with a new device being developed for transcatheter MV replacement are promising, Paul Sorajja tells C. Michael Gibson.

Episode 47: INTREPID

C.  Michael Gibson and Dean Kereiakes discuss the first human use of RUC-4, designed for STEMI point-of-care treatment.

Episode 84: A Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor in STEMI

C. Michael Gibson and William Fearon talk FFR-CT.

Episode 70: FAST-FFR: Accuracy of Fractional Flow Reserve Derived From Coronary Angiography

Dr. C. Michael Gibson talks to Dr. David W. M. Muller about TENDYNE: 1-Year Outcomes of Transcatheter MV Replacement in Patients With Severe Mitral Regurgitation

Episode 35: TENDYNE Trial

C. Michael Gibson and Hiroki Shiomi look at long-term outcomes from RESET.

Episode 67: RESET: Randomized Trial of Sirolimus-Eluting vs Everolimus-Eluting Stents

C. Michael Gibson, Kenneth Rosenfield, and Robert Lookstein discuss the way forward for PERT.

Episode 64: Building a New Backbone Upon Which to Randomize Patients: PERT Registry

C. Michael Gibson gets the details on PREPARE-CALC from Gert Richardt.

Episode 77: PREPARE-CALC: High-speed Rotational Atherectomy Prior to Drug-Eluting Stent Implantation

C. Michael Gibson and Jörg Hausleiter discuss the TRIVALVE trial.

Episode 63: TRIVALVE: Evaluation of Edge-to-Edge Valve Repair

C. Michael Gibson and Pieter Stella discuss ReCre8, which evaluated a polymer-free DES in an all-comers population.

Episode 61: ReCre8: A Randomized Trial Evaluating a Polymer-Free Coronary Drug-Eluting Stent

The best podcasts about ourselves as well as the world through the lense of Science. Specific topics include things about our brain, emotions to biology, physics and more!

Best Episodes on Science, Humans & The World

The best podcast episodes on non-current politics. Covering topics such as universal basic income, democracy, poverty & justice and more. For anyone interested in learning more about politics that affect that world, not just now, but in the longer term. Add episodes you're interested into your queue below!